ArticleBJR case reports2026
Presumed hepatic pseudolipoma detected as a small hepatic surface lesion: multimodality imaging findings.
Article in BJR case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic pseudolipomas are uncommon benign lesions located on or near the liver capsule which are thought to arise from a detached epiploic appendage that becomes trapped near Glisson's capsule. Because these lesions may appear as small hepatic or perihepatic nodules, they can mimic primary or metastatic hepatic tumors on screening imaging. Here, we report the case of a 55-year-old asymptomatic man with no relevant medical history who was referred after routine health-screening ultrasonography revealed a 10 × 8-mm hyperechoic lesion adjacent to the surface of liver segment VI. Liver function tests were normal, hepatitis B and C viral markers were negative, and tumor markers, including carcinoembryonic antigen, carbohydrate antigen 19-9, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist-II, were within the normal ranges. Dynamic ultrasonography demonstrated that the lesion was located along the hepatic capsule, rather than within the deep hepatic parenchyma. Computed tomography showed a well-demarcated hepatic surface lesion with central calcification and surrounding fat attenuation, without any arterial, portal venous, or delayed enhancement. Gadoxetate disodium-enhanced magnetic resonance imaging revealed fat-containing signal characteristics, no hepatobiliary-phase uptake, and no diffusion restriction. The integrated multimodal imaging findings supported a diagnosis of presumed hepatic pseudolipoma, likely originating from a detached epiploic appendage. Recognition of this benign hepatic tumor mimic may help to avoid unnecessary biopsy or surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.